Professor Haitao Lyu., MEASA, FRSC, FRSB Tenured Professor (Associate), School of Chinese Medicine Hong Kong Baptist University, Hong Kong, China Principal Investigator, State Key Lab of Lab of Medical Genomics (SJTU) Principal Investigator, HKBU Institute of Systems Medicine and Health Sciences (HKBU) Deputy Director, Hong Kong Traditional Chinese Medicine Phenome Research Center Deputy Director, Guangzhou-Hong Kong-Macau Universities Joint Laboratory of Interventional Medicine Adjunct Professorship/PhD Supervisor, Macau University of Science and Technology (2020- ) Visiting Professorship, Haihe Laboratory of Modern Chinese Medicine (2024- ) Distinguished Professorship, Henan Province China (2024- ) Elected Member of Class II (Medicine) of European Academy of Sciences and Arts (2024) (MEASA) Fellow of The Royal Society of Chemistry (2021) (FRSC) Fellow of The Royal Society of Biology (2021) (FRSB) Fellow of International Academy of Artificial Intelligence Sciences (2025) Founding Member of The International Academician Alliance (2025) Member, World Association of Young Scientists (2026) Section Editor, Pharmacological Research (Q1 TOP, IF 10.5) (Since 2020- ) Associate Editor, Phytomedicine (Q1 TOP, IF 8.3) (Since 2023- ) Faculty Member, Faculty Opinions (Faculty 1000 Prime) (2021) Scientific Advisory Expert, Danaher (World Top 100 Companies) Life Sciences China (2022) Biography Dr. Haitao Lyu is an Associate Professor (tenured) at the School of Chinese Medicine, Hong Kong Baptist University. He also holds the position of Principal Investigator (PI) at the State Key Laboratory of Medical Genomics（SJTU). Dr. Lyu is a research professor at the Hong Kong Baptist University Shenzhen Research Institute, an elected member of The European Academy of Sciences and Arts and a Fellow of the Royal Society of Chemistry (FRSC) and the Royal Society of Biology (FRSB). He is recognized as a Faculty Opinions (F1000 Prime) expert, and a visiting professorship in Haihe Laboratory of Modern Chinese Medicine (Tianjin, China). In addition, he is the Chief Expert at the Shanghai Academy of Science and Technology Expert Workstation. Previously, Dr. Lyu held the position of principal investigator and professorship (tenured) and PhD supervisor at the Institute of Systems Biomedicine at Shanghai Jiao Tong University. He also served as a principal investigator, PhD supervisor, and assistant dean at the Innovative Drug Research Center of the School of Pharmacy at Chongqing University. Earlier in his career, he worked as a postdoctoral research fellow at the Albert Einstein College of Medicine, the Washington University School of Medicine, and the Massachusetts Institute of Technology (SMART Center). Dr. Lyu's primary research focus lies in the application of cross-disciplinary sciences in life and health, driving the advancement of next-generation functional metabolomics research (STORM and STORM+). He has successfully led more than 17 projects, including the National Key R&D Program and the National Natural Science Foundation of China. His contributions to the field are evidenced by the publication of 69 SCI-indexed papers in authoritative journals within related fields, with 8 highly cited papers in the Essential Science Indicators (ESI). Dr. Lyu has co-edited one English book published by Wiley and one book on traditional Chinese medicine. Apart from his academic achievements, Dr. Lyu holds various positions of responsibility. He serves as the ever Deputy Secretary-General of the Metabolomics Committee of the Chinese Biophysical Society, The Vice Chairman of The Fangjiomics Speciality Committee of Chinese Pharmaceutical Association, the Deputy Secretary-General of the Network Pharmacology Committee of the Chinese Pharmacological Society, and The Vice Chairman of the Drug Metabolism Committee of the Guangdong Pharmacological Society. Furthermore, he actively contributes to the scientific community as an editor for Pharmacological Research (Section), former Associate Editor for Royal Society Open Science, Associate Editor for Phytomedicine, and an editorial board member for Proteomics, European Journal of Pharmacology, and Chinese Medicine. His expertise is also sought after as an expert reviewer for the National Natural Science Foundation of China, the Ministry of Science and Technology, the Hong Kong Health and Medical Research Fund, NHMRC in Australia. Dr. Lyu's outstanding contributions have been recognized through several prestigious awards, including the 2021 Agilent Technologies Global Competitive ACT-UR Award, the 2022 Faculty Opinions Member of The Year Award, the 2013 QUT Vice Chancellor Research Fellowship, the 2022 APSB Outstanding Editorial Board Member Award, 2023 The Outstanding Editorial Board Member Award (Chinese Medicine Journal), 2023 The Outstanding Editorial Board Member Award (Acupuncture and Herbal Medicine), 2025 Springer Nature Editor of Distinction Award.